HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $262,000 | -9.7% | 16,900 | 0.0% | 0.02% | +25.0% |
| Q2 2019 | $290,000 | +6.6% | 16,900 | 0.0% | 0.02% | -4.8% |
| Q1 2019 | $272,000 | -55.4% | 16,900 | -59.5% | 0.02% | -57.1% |
| Q4 2018 | $610,000 | -36.7% | 41,687 | -21.4% | 0.05% | +133.3% |
| Q3 2018 | $964,000 | -43.4% | 53,031 | -47.5% | 0.02% | -34.4% |
| Q2 2018 | $1,703,000 | +252.6% | 100,933 | +309.3% | 0.03% | +255.6% |
| Q1 2018 | $483,000 | +403.1% | 24,662 | +418.4% | 0.01% | +350.0% |
| Q4 2017 | $96,000 | – | 4,757 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |